Drug
Urokinase-Type Plasminogen Activator clinical trials
Also written Urokinase.
Keep track of what changes. Save the Urokinase-Type Plasminogen Activator studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2020 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 9
medac GmbH (2) · National Healthcare Group, Singapore (1) · The First Affiliated Hospital of Zhengzhou University (1) · Spanish Society of Pediatric Surgery (1) · Beijing Chao Yang Hospital (1) · Second Affiliated Hospital of Nanchang University (1) · GWT-TUD GmbH (1) · University of Roma La Sapienza (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Urokinase-Type Plasminogen Activator is read from its arms, and is right about nine times in ten.
Testing it · 11
- Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)RecruitingPhase 4Second Affiliated Hospital of Nanchang UniversityNCT06284642Written as Urokinase
- Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: a Randomized Controlled TrialCompletedPhase 4National Healthcare Group, SingaporeNCT06802679Written as Urokinase
- Thrombolysis of Urokinase for Minor StrokeCompletedPhase 3The First Affiliated Hospital of Zhengzhou UniversityNCT04420351Written as Urokinase thrombolysis
- Local Thrombolytics Before Thrombectomy in STEMIStatus unknownPhase 4University of Roma La SapienzaNCT01568931Written as Urokinase
- Urokinase Therapy in Patients With Diabetic Foot SyndromeTerminatedPhase 3medac GmbHNCT00823225Written as Urokinase
- Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb IschemiaTerminatedPhase 3GWT-TUD GmbHNCT01638585Written as urokinase
- Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in ChildhoodCompletedPhase 3Spanish Society of Pediatric SurgeryNCT00798278Written as Urokinase
- Intrapleural Urokinase for Retained HemothoraxStatus unknownPhase 3National Taiwan University HospitalNCT01134237Written as urokinase
- Urokinase Therapy in Diabetic Foot SyndromeCompletedPhase 2medac GmbHNCT00537498Written as Urokinase
- 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in ChinaCompletedPhase 4Beijing Chao Yang HospitalNCT00799968Written as Urokinase
- Dornase Alfa and Urokinase for Kids With Pleural EmpyemaStatus unknownPhase 2/3Azienda Ospedaliera di PadovaNCT00502632Written as Urokinase and Dornase alfa
Given in every arm · 1 — Urokinase-Type Plasminogen Activator is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Urokinase-Type Plasminogen Activator
Codes
What other systems call Urokinase-Type Plasminogen Activator · ClinicalTrials.gg INT008388
- UNII (FDA) 83G67E21XIUROKINASEConfirmed FDA, Wikidata
- RxNorm 11055Confirmed FDA, Wikidata
- Wikidata Q110969665urokinaseConfirmed FDA, Wikidata
- DrugBank DB00013One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 83G67E21XI | UROKINASE | Confirmed FDA, Wikidata |
| RxNorm | 11055 | — | Confirmed FDA, Wikidata |
| Wikidata | Q110969665 | urokinase | Confirmed FDA, Wikidata |
| DrugBank | DB00013 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.